Woodhouse, Lisa J.
Appleton, Jason P.
Christensen, Hanne
Dineen, Rob A.
England, Timothy J.
James, Marilyn
Krishnan, Kailash
Montgomery, Alan A.
Ranta, Anna
Robinson, Thompson G.
Sprigg, Nikola
Bath, Philip M.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
https://doi.org/10.1136/svn-2018-000168
Intensive antiplatelet therapy with three agents does not reduce risk of another stroke
https://doi.org/10.1136/dtb.2019.000058
Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia
https://doi.org/10.1038/s41598-023-38474-2
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT (Results)
https://doi.org/10.3310/hta22480
Funding for this research was provided by:
Health Technology Assessment Programme (10/104/24, 10/104/24, 10/104/24, 10/104/24, 10/104/24, 10/104/24, 10/104/24, 10/104/24, 10/104/24, 10/104/24, 10/104/24)
National Institute for Health Research (Health and Care Research Scholarship)
Nottingham University Hospitals NHS Trust Research & Innovation Award
British Heart Foundation (PG/08/083/25779, PG/08/083/25779, PG/08/083/25779, PG/08/083/25779, PG/08/083/25779, PG/08/083/25779, PG/08/083/25779)
Article History
Received: 16 August 2022
Accepted: 9 July 2023
First Online: 20 July 2023
Competing interests
: LJW and JPA were funded in part by NIHR TARDIS (10/104/24). JPA was supported, in part, by a NIHR Health and Care Research Scholarship, and is supported by a Nottingham University Hospitals NHS Trust Research & Innovation Award. TGR is a NIHR Senior Investigator. PMB is Stroke Association Professor of Stroke Medicine and an emeritus NIHR Senior Investigator; he has consulted for DiaMedica, Moleac, Phagenesis and Roche. Remaining authors (HC, RAD, TJE, MJ, KK, AAM, AR, NS) report no declarations.